Raw data from JAAD research letter: Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign"
Published: 7 June 2020| Version 1 | DOI: 10.17632/tphxzjkrh8.1
Contributors:
Carlos Gustavo Wambier, Sergio Vaño-Galván, Andy GorenDescription
Raw data of the JAAD Research Letter: Androgenetic alopecia present in the majority of patients hospitalized with COVID-19 - The "Gabrin Sign". (10.1016/j.jaad.2020.05.079). Data of patients admitted due to severe COVID-19 in three Madrid hospitals. The study took place from March 23, 2020 to April 12, 2020. Dermatologists recorded the age, gender and alopecia diagnosis. Alopecia severity was evaluated using the Hamilton–Norwood scale (HNS) for males and the Ludwig scale (LS) for females.
Files
Categories
Dermatology, Androgen, Alopecia, Vulnerability, Male Pattern Baldness, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19